These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?]. Yamaguchi T, Sugimoto T. Clin Calcium; 2009 Jan; 19(1):38-43. PubMed ID: 19122263 [Abstract] [Full Text] [Related]
4. [Alendronate for treatment of osteoporoses]. Harada A. Nihon Rinsho; 2009 May; 67(5):943-7. PubMed ID: 19432114 [Abstract] [Full Text] [Related]
7. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC, Fracture Intervention Trial Steering Committee, HORIZON Pivotal Fracture Trial Steering Committee. N Engl J Med; 2010 May 13; 362(19):1761-71. PubMed ID: 20335571 [Abstract] [Full Text] [Related]
8. Bisphosphonates and atypical femoral fractures: a time for reflection. Compston JE. Maturitas; 2010 Jan 13; 65(1):3-4. PubMed ID: 19932574 [No Abstract] [Full Text] [Related]
18. [Is SSBT associated with atypical femoral fracture? SSBT isn't associated with atypical femoral fracture]. Soen S. Clin Calcium; 2012 Jun 13; 22(6):919-22. PubMed ID: 22653034 [Abstract] [Full Text] [Related]
19. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture. Cross MB, Nam D, van der Meulen MC, Bostrom MP. J Bone Joint Surg Br; 2012 Jul 13; 94(7):994-7. PubMed ID: 22733959 [Abstract] [Full Text] [Related]